Toll-like receptors in transplantation: Sensing and reacting to injury

Kidney International

Volumn 81, Issue 9, 2012, Pages 826-832

  Leventhal, Jeremy S ^a   Schröppel, Bernd ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

delayed graft function; kidney transplantation; renal ischemia reperfusion

Indexed keywords

HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6;

ADAPTIVE IMMUNITY; GRAFT SURVIVAL; HUMAN; KIDNEY CELL; KIDNEY TRANSPLANTATION; LIVER CELL; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE INJURY; TRANSPLANTATION TOLERANCE;

EID: 84859767406     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.498     Document Type: Short Survey

References (38)

1. Yamamoto M, Takeda K. Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract 2010; 2010: 240365.
2. Goncalves GM, Castoldi A, Braga TT et al. New roles for innate immune response in acute and chronic kidney injuries. Scand J Immunol 2011; 73: 428-435.
3. Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med 2010; 14: 2592-2603.
4. Yang H, Hreggvidsdottir HS, Palmblad K et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010; 107: 11942-11947.
5. Tsan MF, Gao B. Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J Endotoxin Res 2007; 13: 6-14. (Pubitemid 47471330)
6. Wu H, Ma J, Wang P et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010; 21: 1878-1890.
7. Wu H, Chen G, Wyburn KR et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859. (Pubitemid 47529615)
8. Chen J, John R, Richardson JA et al. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 2010; 79: 288-299.
9. Zhang B, Ramesh G, Uematsu S et al. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 2008; 19: 923-932.
10. Wolfs TG, Buurman WA, van Schadewijk A et al. In vivo expression of Tolllike receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 2002; 168: 1286-1293. (Pubitemid 34094497)
11. El-Achkar TM, Wu XR, Rauchman MI et al. Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression. Am J Physiol Renal Physiol 2008; 295: F534-F544.
12. Banas MC, Banas B, Hudkins KL et al. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008; 19: 704-713.
13. Leemans JC, Stokman G, Claessen N et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894-2903. (Pubitemid 41434417)
14. Pulskens WP, Teske GJ, Butter LM et al. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 2008; 3: e3596.
15. Shigeoka AA, Holscher TD, King AJ et al. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol 2007; 178: 6252-6258. (Pubitemid 46717408)
16. Rusai K, Sollinger D, Baumann M et al. Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 2010; 25: 853-860.
17. Mkaddem SB, Werts C, Goujon JM et al. Heat shock protein gp96 interacts with protein phosphatase 5 and controls toll-like receptor 2 (TLR2)-mediated activation of extracellular signal-regulated kinase (ERK) 1/2 in post-hypoxic kidney cells. J Biol Chem 2009; 284: 12541-12549.
18. Kruger B, Krick S, Dhillon N et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
19. Dhillon N, Walsh L, Kruger B et al. A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. J Hepatol 2010; 53: 67-72.
20. Tsung A, Klune JR, Zhang X et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007; 204: 2913-2923. (Pubitemid 350179560)
21. Goldstein DR, Tesar BM, Akira S et al. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571-1578. (Pubitemid 38063290)
22. Tesar BM, Zhang J, Li Q et al. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein. Am J Transplant 2004; 4: 1429-1439. (Pubitemid 39159057)
23. McKay D, Shigeoka A, Rubinstein M et al. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006; 36: 1994-2002. (Pubitemid 44251746)
24. Zhang N, Kruger B, Lal G et al. Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival. Immunol Lett 2010; 127: 119-125.
25. Thornley TB, Brehm MA, Markees TG et al. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol 2006; 176: 1561-1570. (Pubitemid 43134300)
26. Chen L, Wang T, Zhou P et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282-2291. (Pubitemid 44359413)
27. Lal G, Yin N, Xu J et al. Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function. Am J Transplant 2011; 11: 203-214.
28. Walker WE, Nasr IW, Camirand G et al. Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 2006; 177: 5307-5316. (Pubitemid 44527603)
29. Kruger B, Yin N, Zhang N et al. Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. Eur J Immunol 2010; 40: 2914-2924.
30. Matsuoka N, Itoh T, Watarai H et al. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J Clin Invest 2010; 120: 735-743.
31. Huang Y, Yin H, Han J et al. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007; 7: 799-808. (Pubitemid 46481209)
32. Tesar BM, Jiang D, Liang J et al. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 2006; 6: 2622-2635. (Pubitemid 44571682)
33. Testro AG, Visvanathan K, Skinner N et al. Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4. J Gastroenterol Hepatol 2011; 26: 155-163.
34. Wang S, Schmaderer C, Kiss E et al. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88-and TRIFdependent signaling. Dis Model Mech 2010; 3: 92-103.
35. Braudeau C, Ashton-Chess J, Giral M et al. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance vs. chronic rejection in kidney transplant recipients. Transplantation 2008; 86: 130-136.
36. Ducloux D, Deschamps M, Yannaraki M et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005; 67: 2454-2461. (Pubitemid 41623410)
37. Methe H, Zimmer E, Grimm C et al. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004; 78: 1324-1331. (Pubitemid 39507972)
38. Palmer SM, Burch LH, Davis RD et al. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003; 168: 628-632. (Pubitemid 37175964)